|
|
|
|
|
by rsynnott
1888 days ago
|
|
The moral of the story is, don't contract to deliver 100 million widgets in a quarter and then actually deliver 30 million widgets. It's pretty simple; remove the vaccine context and there's nothing at all controversial going on here. Missing production forecasts is one thing, but missing them by this much is unusual and will usually result in trouble for the manufacturer. Really, I'd say it's more the case that Oxford is regretting working with AZ, rather than a more established vaccine manufacturer. |
|